34 results
8-K
EX-1.1
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
29 Jun 23
Entry into a Material Definitive Agreement
4:13pm
Accounting Oversight Board (“PCAOB”), (ii) in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01
DEF 14A
7vdm051i4 vovq
26 Apr 23
Definitive proxy
4:31pm
8-K
61pq8e
11 Apr 22
Entry into a Material Definitive Agreement
4:40pm
DEFR14A
0jpackpzmvehgrhwok0
4 Mar 22
Revised proxy
4:06pm
DEFA14A
EX-10.1
prhd7gdp4iigy
25 Feb 22
Additional proxy soliciting materials
4:28pm
8-K
EX-10.1
j1e5kcsf9e
25 Feb 22
Entry into a Material Definitive Agreement
4:27pm
PRER14A
y6n7fcn4 6f
16 Dec 21
Preliminary revised proxy
12:00am